Primary sclerosing cholangitis: what is the role of ursodeoxycholic acid in therapy for PSC? Primary sclerosing cholangitis: what is the role of ursodeoxycholic acid in therapy for PSC? Nat Rev Gastroenterol Hepatol
235
As noted above, ursodeoxycholic acid is currently used in patients with primary biliary cirrhosis who have abnormal liver biochemical values
Few studies have been conducted using UDCA in indirect hyperbilirubinemia
Ursodeoxycholic acid (UDCA) has been proved effective in reducing the recurrence of CBDS
Methods This was a retrospective analysis of the prospectively collected data of patients with morbid obesity
As the therapeutically active component of bear bile, it has been used for centuries in traditional Chinese medicine to treat a range of conditions, while manufactured UDCA has been used for decades in Western medicine to treat
On the other hand, ursodeoxycholic acid (UDCA) is a naturally occurring tertiary dihydroxy hydrophilic bile acid used with considerable success in the treatment of primary biliary cirrhosis
This systematic review did not demonstrate any significant benefits of ursodeoxycholic acid on all-cause mortality, all-cause mortality or liver transplantation, pruritus, or fatigue in patients with primary biliary cirrhosis
S
Potential role of ursodeoxycholic acid in suppression of nuclear factor kappa B in microglial cell line (BV-2) Arch Pharm
The role of ursodeoxycholic acid (UDCA) in cholelithiasis management after one anastomosis gastric bypass (OAGB) for morbid obesity: results of a monocentric